-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
GeneDx Holdings Corp. quarterly/annual Income Tax Expense (Benefit) history and change rate from 2019 to Q3 2025.
- GeneDx Holdings Corp. Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was $247K.
- GeneDx Holdings Corp. Income Tax Expense (Benefit) for the twelve months ending September 30, 2025 was $424K.
- GeneDx Holdings Corp. annual Income Tax Expense (Benefit) for 2024 was -$343K, a 63% increase from 2023.
- GeneDx Holdings Corp. annual Income Tax Expense (Benefit) for 2023 was -$926K, a 98.1% increase from 2022.
- GeneDx Holdings Corp. annual Income Tax Expense (Benefit) for 2022 was -$49.1M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Change (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Change (%)